Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

Market Cap	37.34B -18.8%
Revenue (ttm)	4.55B +2.5%
Net Income	1.65B -10.9%
EPS	2.10 -10.9%
Shares Out	785.72M
PE Ratio	22.63
Forward PE	20.44
Dividend	1.30 (2.78%)
Ex-Dividend Date	May 28, 2025

Volume	8,302,719
Average Volume	4,435,861
Open	45.48
Previous Close	46.77
Day's Range	45.48 - 49.16
52-Week Range	43.85 - 71.51
Beta	-0.22
RSI	53.05
Earnings Date	Apr 28, 2026

About SHE:300832

Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1995
• Employees: 2,841
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300832

Financial Performance

In 2024, SHE:300832's revenue was 4.54 billion, an increase of 15.41% compared to the previous year's 3.93 billion. Earnings were 1.83 billion, an increase of 10.57%.